The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...

Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...

The "Diabetic Macular Edema (DME): Epidemiology Forecast to 2034" report has been added to ResearchAndMarkets.com's offering. In the 7MM, the diagnosed prevalent cases of DME in diabetes are expected ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In support of improving patient care, this activity has ...

Armed with a recent authorization from the FDA, eye specialists are offering light therapy to patients with non-exudative (dry) age-related macular degeneration (AMD), aiming to stop or even reverse ...